Managing Resistant Hypertension: Focus on Mineralocorticoid-Receptor Antagonists

Vascular Health and Risk Management
doi 10.2147/vhrm.s138599
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Third-Generation Mineralocorticoid Receptor Antagonists

Journal of Cardiovascular Pharmacology
Cardiovascular MedicinePharmacologyCardiology
2016English

Mineralocorticoid Receptor Antagonists for Heart Failure

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2011English

New Evidence Supporting the Use of Mineralocorticoid Receptor Blockers in Drug-Resistant Hypertension

Current Hypertension Reports
Internal Medicine
2016English

Mineralocorticoid Receptor Antagonists (MRAs): More Attention Required (To Prescription)!

Kardiologia Polska
Cardiovascular MedicineCardiology
2018English

Mineralocorticoid Receptor Antagonists: New Extended Roles in Cardio- And Nephroprotection

Medical Council
2018English

Effects of Mineralocorticoid Receptor Antagonists in Patients With Hypertension and Diabetes Mellitus: A Systematic Review and Meta-Analysis

Journal of Human Hypertension
Internal Medicine
2015English

Structure-Based Drug Design of Mineralocorticoid Receptor Antagonists to Explore Oxosteroid Receptor Selectivity

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2016English

Mineralocorticoid Receptor Antagonists for Heart Failure: Systematic Review and Meta-Analysis

BMC Cardiovascular Disorders
Cardiovascular MedicineCardiology
2016English

Mineralocorticoid Receptor Antagonists for Heart Failure: A Real-Life Observational Study

ESC heart failure
Cardiovascular MedicineCardiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy